SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]:
SEC Accession No. 0001104659-18-041796
Filing Date
2018-06-22
Accepted
2018-06-22 16:05:28
Documents
6
Effectiveness Date
2018-06-22

Document Format Files

Seq Description Document Type Size
1 S-1MEF a18-15809_1s1mef.htm S-1MEF 88319
2 EX-5.1 a18-15809_1ex5d1.htm EX-5.1 14894
3 EX-8.1 a18-15809_1ex8d1.htm EX-8.1 12959
4 EX-23.1 a18-15809_1ex23d1.htm EX-23.1 3229
5 GRAPHIC g158091kmi001.jpg GRAPHIC 2552
6 GRAPHIC g158091kwi001.jpg GRAPHIC 2682
  Complete submission text file 0001104659-18-041796.txt   127955
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1MEF | Act: 33 | File No.: 333-225823 | Film No.: 18914571
SIC: 2834 Pharmaceutical Preparations